As filed with the Securities and Exchange Commission on March 23, 2018
Registration No. 333-                                   
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM S-8 
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 
CHROMADEX CORPORATION
(Exact name of registrant as specified in its charter)
 
 
Delaware
 
26-2940963
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
10005 Muirlands Boulevard
Suite G
Irvine, CA 92618
(949) 419-0288
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) 
 
 
2017 Equity Incentive Plan
 (Full title of the plan)
 
 
Frank L. Jaksch, Jr.
Chief Executive Officer
10005 Muirlands Boulevard
Suite G
Irvine, CA 92618
(949) 419-0288
(Name, address, including zip code, and telephone number, including area code, of agent for service)
 
 
Copies to:
 
  Thomas A. Coll
Matthew T. Browne
Cooley LLP
4401 Eastgate Mall
San Diego, CA 92121
(858) 550-6000
Kevin M. Farr
Chief Financial Officer
10005 Muirlands Boulevard
Suite G
Irvine, CA 92618
(949) 419-0288
 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
Accelerated filer
Non-accelerated filer (Do not check if a smaller reporting company)
Smaller reporting company
Emerging growth company
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
 
 
 
 
 
CALCULATION OF REGISTRATION FEE
 
 
Title of securities
to be registered
 
 
Amount to be registered (1)(2)
 
 
Proposed
maximum
offering price
per share (3)
 
 
Proposed maximum aggregate offering price (3)
 
 
Amount of registration fee
 
2017 Equity Incentive Plan
Common Stock, par value $0.001 per share
 
500,000 shares
  $ 5.65  
  $ 2,825,000  
  $ 351.72  
 
 
 
 
(1)
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (“Common Stock”) that become issuable under the ChromaDex Corporation 2017 Equity Incentive Plan, as amended (the “2017 Plan”), by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.
(2)
Represents 500,000 shares of Common Stock pursuant to a stock option that was granted pursuant to the 2017 Plan in compliance with NASDAQ Listing Rule 5635(c)(4) (the "Inducement Award").
(3)
The proposed maximum aggregate offering price per share and proposed maximum aggregate offering price are based upon the exercise price of the Inducement Award.
 
 
 
 
 
INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION
STATEMENT ON FORM S-8 NO. 333-221246
 
This Registration Statement on Form S-8 is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement on Form S-8 relating to the same benefit plan are effective.  This Registration Statement on Form S-8 registers the offer and sale of an additional 500,000 shares of the Registrant’s common stock for issuance under the ChromaDex Corporation 2017 Equity Incentive Plan, as amended (the “ 2017 Plan ”), pursuant to a stock option (the “ Inducement Award ”) that was granted to an individual entering into employment with the Registrant within the meaning of Rule 5635(c)(4) of the NASDAQ Listing Rules (“ Rule 5635(c)(4) ”). The 2017 Plan was amended by the Board of Directors of the Registrant to provide for the Inducement Award without stockholder approval as permitted by Rule 5635(c)(4).  The Registrant previously registered shares of its common stock for issuance under the 2017 Plan on a Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the “SEC”) on October 31, 2017 (File No. 333-221246) (the “ Prior Registration Statement ”). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Prior Registration Statement.
 
ITEM 8. EXHIBITS.
 
 
 
Exhibit Number
 
Description
 
 
 
Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference from, and filed as Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K (File No. 001-37752) filed with the SEC on March 15, 2018).
 
 
Certificate of Amendment to the Certificate of Incorporation of the Registrant (incorporated by reference from, and filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 000-53290) filed with the SEC on April 12, 2016).
 
 
Bylaws of the Registrant (incorporated by reference from, and filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 333-140056) filed with the SEC on June 24, 2008).
 
 
Amendment to Bylaws of the Registrant (incorporated by reference from, and filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37752) filed with the SEC on July 19, 2016).
 
 
Form of Stock Certificate representing shares of the Registrant’s Common Stock (incorporated by reference from, and filed as Exhibit 4.1 of the Registrant’s Annual Report on Form 10-K (File No. 000-53290) filed with the SEC on April 3, 2009).
 
 
Investor’s Rights Agreement, effective as of December 31, 2005, by and between The University of Mississippi Research Foundation and the Registrant (incorporated by reference from, and filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No. 333-140056) filed with the SEC on June 24, 2008).
 
 
Tag-Along Agreement effective as of December 31, 2005, by and among the Registrant, Frank Louis Jaksch, Snr. & Maria Jaksch, Trustees of the Jaksch Family Trust, Margery Germain, Lauren Germain, Emily Germain, Lucie Germain, Frank Louis Jaksch, Jr., and the University of Mississippi Research Foundation (incorporated by reference from, and filed as Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 333-140056) filed with the SEC on June 24, 2008).
 
 
Form of Stock Certificate representing shares of the Registrant’s Common Stock (new design effective as of January 1, 2016, incorporated by reference from and filed as Exhibit 4.4 to the Registrant’s Annual Report on Form 10-K (File No. 000-53290) filed with the SEC on March 17, 2016).
 
 
Opinion of Cooley LLP.
 
 
Consent of Marcum LLP.
 
 
Consent of Cooley LLP. Reference is made to Exhibit 5.1.
 
 
Power of Attorney. Reference is made to the signature page hereto.
 
 
ChromaDex Corporation 2017 Equity Incentive Plan, as amended, and Form of Option Grant Notice, Form of Option Agreement, Form of Restricted Stock Award Grant Notice, Form of Restricted Stock Award Agreement, Form of Restricted Stock Unit Award Grant Notice and Form of Restricted Stock Unit Award Agreement thereunder (incorporated by reference from, and filed as Exhibit 10.66 to the Registrant's Annual Report on Form 10-K (File No. 001-37752) filed with the SEC on March 15, 2018).
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irvine, State of California, on March 23, 2018.
 
 
 
CHROMADEX CORPORATION
 
 
By:
 
/s/ Frank L. Jaksch Jr.  
 
 
Frank L. Jaksch Jr.
 
 
Chief Executive Officer
 
 
POWER OF A T TORNEY
 
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Frank L. Jaksch Jr. and Kevin M. Farr, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
 
Signature
 
Title
 
Date
 
 
 
/s/ FRANK L. JAKSCH JR.
Frank L. Jaksch Jr.
 
Chief Executive Officer and Director
(Principal Executive
Officer)
 
 
March 23, 2018
 
/s/ KEVIN M. FARR
Kevin M. Farr
 
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
 
March 23, 2018
 
/s/ ROBERT FRIED
Robert Fried
 
 
President, Chief Operating Officer, and Director
 
 
March 23, 2018
 
/s/ STEPHEN ALLEN
Stephen Allen
 
 
Chairman of the Board and Director
 
March 23, 2018
 
/s/ STEPHEN BLOCK
Stephen Block
 
 
Director
 
March 23, 2018
 
/s/ JEFF BAXTER
Jeff Baxter
 
 
Director
 
March 23, 2018
 
/s/ KURT GUSTAFSON
Kurt Gustafson
 
 
Director
 
March 23, 2018
 
/s/ TONY LAU
Tony Lau
 
 
Director
 
March 23, 2018
 
/s/ STEVEN RUBIN
Steven Rubin
 
 
Director
 
March 23, 2018
 
/s/ WENDY YU
Wendy Yu
 
 
Director
 
March 23, 2018
 
 
 
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ChromaDex Charts.
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ChromaDex Charts.